Anna Feduccia
Clinical Researcher
Papers
Trials
Key Impact
A leading contributor to clinical development and trial design of MDMA‑assisted psychotherapy, particularly for PTSD and trauma-related disorders.
Background & Research
Anna Feduccia is a clinical researcher known for her central role in the clinical development of MDMA‑assisted psychotherapy. Working collaboratively with multidisciplinary teams (including investigators associated with the Multidisciplinary Association for Psychedelic Studies, MAPS), she has contributed to a series of phase 2 randomised controlled trials, pooled longitudinal analyses, and the rationale and design work that supported advancement to phase 3 trials. Her work spans dose‑response and safety evaluations in populations with severe post‑traumatic stress disorder (including military veterans, first responders, and others), investigation of long‑term outcomes after psychedelic‑assisted psychotherapy, and pilot studies exploring MDMA‑assisted therapy for anxiety and psychological distress associated with life‑threatening illness.